Medullary thyroid cancer epidemiology and demographics
Medullary thyroid cancer Microchapters |
Differentiating Medullary thyroid cancer from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Medullary thyroid cancer epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Medullary thyroid cancer epidemiology and demographics |
FDA on Medullary thyroid cancer epidemiology and demographics |
CDC on Medullary thyroid cancer epidemiology and demographics |
Medullary thyroid cancer epidemiology and demographics in the news |
Blogs on Medullary thyroid cancer epidemiology and demographics |
Risk calculators and risk factors for Medullary thyroid cancer epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
The incidence of medullary thyroid cancer is approximately 14.3 per 100,000 individuals worldwide. The incidence of medullary thyroid cancer increases with age; Sporadic form of medullary thyroid cancer commonly presents in the fifth and sixth decade of life. The familial form tends to appear earlier in life.
Epidemiology and Demographics
Incidence
- The overall incidence of thyroid cancer is approximately 14.3 per 100,000 individuals worldwide.[1][2]
Age
- The incidence of medullary thyroid cancer increases with age.[3]
- Sporadic form of medullary thyroid cancer commonly presents in the fifth and sixth decade of life.[4]
- The familial form tends to appear earlier in life.
Gender
- Medullary thyroid cancer affects women more frequently than men. However, this gender disparity tends to decrease by advancing the age of individuals.[3]
Race
- Medullaty thyroid cancer is more common among white and hispanic ethnicities than Asian/Pacific Islanders and blacks.[3][5]
Case fatality/Mortality rate
- The overall mortality rate of thyroid cancer is 0.5 per 100,000 worldwide.[2]
References
- ↑ Davies, Louise; Welch, H. Gilbert (2006). "Increasing Incidence of Thyroid Cancer in the United States, 1973-2002". JAMA. 295 (18): 2164. doi:10.1001/jama.295.18.2164. ISSN 0098-7484.
- ↑ 2.0 2.1 Davies, Louise; Welch, H. Gilbert (2014). "Current Thyroid Cancer Trends in the United States". JAMA Otolaryngology–Head & Neck Surgery. 140 (4): 317. doi:10.1001/jamaoto.2014.1. ISSN 2168-6181.
- ↑ 3.0 3.1 3.2 Aschebrook-Kilfoy, Briseis; Ward, Mary H.; Sabra, Mona M.; Devesa, Susan S. (2011). "Thyroid Cancer Incidence Patterns in the United States by Histologic Type, 1992–2006". Thyroid. 21 (2): 125–134. doi:10.1089/thy.2010.0021. ISSN 1050-7256.
- ↑ Wells, Samuel A.; Asa, Sylvia L.; Dralle, Henning; Elisei, Rossella; Evans, Douglas B.; Gagel, Robert F.; Lee, Nancy; Machens, Andreas; Moley, Jeffrey F.; Pacini, Furio; Raue, Friedhelm; Frank-Raue, Karin; Robinson, Bruce; Rosenthal, M. Sara; Santoro, Massimo; Schlumberger, Martin; Shah, Manisha; Waguespack, Steven G. (2015). "Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma". Thyroid. 25 (6): 567–610. doi:10.1089/thy.2014.0335. ISSN 1050-7256.
- ↑ Lairmore, Terry C.; Diesen, Diana; Goldfarb, Melanie; Milas, Mira; Ying, Anita K.; Sharma, Jyotirmay; McIver, Bryan; Wong, Richard J.; Randolph, Greg (2015). "AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: TIMING OF MULTIPLE ENDOCRINE NEOPLASIA THYROIDECTOMY AND EXTENT OF CENTRAL NECK LYMPHADENECTOMY". Endocrine Practice. 21 (7): 839–847. doi:10.4158/EP14463.DSCR. ISSN 1530-891X.